CAMBRIDGE, Mass. - Moderna said Monday that its COVID-19 vaccine booster appears to provide protection against the rapidly-spreading omicron variant of the coronavirus, but it will still continue work developing a new shot specific to the strain.
The drug company said in a statement that preliminary data showed its booster shot currently being used in the U.S. and abroad increased neutralizing antibody levels against omicron 37-fold compared to pre-boost levels.
A double dose of the booster — 100ug — provided an 83-fold increase in neutralizing antibody levels, the company said.The news comes amid warnings about the variant’s rapid spread around the world, which has been detected in at least 89 countries.